Search research articles
Contact Us
Filters
Showing results (571-580 of 934) with videos related to
Page
of 94
Sort By:
The American Journal of Cardiology
|
April 26, 2008
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy
C Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of the American Heart Association
|
October 30, 2018
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
Antonio J Vallejo-Vaz, Henry N Ginsberg, Michael H Davidson, et al.
American Heart Journal
|
December 12, 2017
Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry
Celina M Yong, Yuyin Liu, Patricia Apruzzese, et al.
The American Journal of Cardiology
|
March 23, 2011
Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry)
Farhad Abtahian, Benjamin Olenchock, Fang-Shu Ou, et al.
Journal of the American Heart Association
|
August 9, 2021
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry
Suzanne V Arnold, Christopher P Cannon, James A de Lemos, et al.
American Heart Journal
|
January 31, 2006
Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies
James L Januzzi, L Kristin Newby, Sabina A Murphy, et al.
Cancer
|
October 13, 2006
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas
Christopher P Cannon, Matthew T Ballo, Gunar K Zagars, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 6, 2016
Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy
Evangelos Giannitsis, Lars Wallentin, Stefan K James, et al.
Circulation
|
July 10, 2002
Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction
Graham C Wong, David A Morrow, Sabina Murphy, et al.
Diabetologia
|
March 5, 2021
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial
David Z I Cherney, Bernard Charbonnel, Francesco Cosentino, et al.
Page
of 94
Search research articles
Search
Showing results (571-580 of 934) with videos related to
Sort By:
Page
of 94
The American Journal of Cardiology
|
April 26, 2008
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy
C Michael Gibson, Yuri B Pride, Jacqueline L Buros, et al.
Journal of the American Heart Association
|
October 30, 2018
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials
Antonio J Vallejo-Vaz, Henry N Ginsberg, Michael H Davidson, et al.
American Heart Journal
|
December 12, 2017
Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry
Celina M Yong, Yuyin Liu, Patricia Apruzzese, et al.
The American Journal of Cardiology
|
March 23, 2011
Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry)
Farhad Abtahian, Benjamin Olenchock, Fang-Shu Ou, et al.
Journal of the American Heart Association
|
August 9, 2021
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry
Suzanne V Arnold, Christopher P Cannon, James A de Lemos, et al.
American Heart Journal
|
January 31, 2006
Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies
James L Januzzi, L Kristin Newby, Sabina A Murphy, et al.
Cancer
|
October 13, 2006
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas
Christopher P Cannon, Matthew T Ballo, Gunar K Zagars, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 6, 2016
Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy
Evangelos Giannitsis, Lars Wallentin, Stefan K James, et al.
Circulation
|
July 10, 2002
Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction
Graham C Wong, David A Morrow, Sabina Murphy, et al.
Diabetologia
|
March 5, 2021
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial
David Z I Cherney, Bernard Charbonnel, Francesco Cosentino, et al.
Page
of 94